116 related articles for article (PubMed ID: 22994727)
21. [Costs of population cervical cancer screening program in Poland between 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
[TBL] [Abstract][Full Text] [Related]
22. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
Annemans L; Rémy V; Lamure E; Spaepen E; Lamotte M; Muchada JP; Largeron N
J Med Econ; 2008; 11(1):135-50. PubMed ID: 19450115
[TBL] [Abstract][Full Text] [Related]
23. Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland.
Ginindza TG; Sartorius B; Dlamini X; Östensson E
PLoS One; 2017; 12(5):e0177762. PubMed ID: 28531205
[TBL] [Abstract][Full Text] [Related]
24. Management of Chronic Kidney Disease in Morocco: A Cost-of-Illness Study.
Chrifi Alaoui A; Elomari M; Qarmiche N; Kouiri O; Chouhani BA; El Rhazi K; El Fakir S; Sqalli Houssaini T; Tachfouti N
Cureus; 2023 Jun; 15(6):e40537. PubMed ID: 37461782
[TBL] [Abstract][Full Text] [Related]
25. Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study.
Shi JF; Chen JF; Canfell K; Feng XX; Ma JF; Zhang YZ; Zhao FH; Li R; Ma L; Li ZF; Lew JB; Ning Y; Qiao YL
BMC Health Serv Res; 2012 May; 12():123. PubMed ID: 22624619
[TBL] [Abstract][Full Text] [Related]
26. Medical costs for the treatment of cervical cancer at central hospitals in Vietnam.
Nguyen AD; Hoang MV; Nguyen CC
Health Care Women Int; 2018 Apr; 39(4):442-449. PubMed ID: 29125392
[TBL] [Abstract][Full Text] [Related]
27. Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer.
Manusirivithaya S; Sripramote M; Tangjitgamol S; Sanjareonsuttikul N; Pisarnturakit P
J Med Assoc Thai; 2005 Aug; 88(8):1035-44. PubMed ID: 16404829
[TBL] [Abstract][Full Text] [Related]
28. [Study on direct economic burden and influencing factors in patients with cervical cancer and precancerous lesions].
Tao SY; Peng JR; Wang Y; Zhang GT; Chen ZY; Zhao F; Ma JQ; Yang X; Qiao YL; Zhao FH; Yang CX
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Dec; 52(12):1281-1286. PubMed ID: 30522231
[No Abstract] [Full Text] [Related]
29. A cost comparison of two strategies for treating stage IB2 cervical cancer.
Lachance JA; Darus CJ; Stukenborg GJ; Schneider BF; Rice LW; Jazaeri AA
Int J Gynecol Cancer; 2008; 18(2):274-8. PubMed ID: 18334009
[TBL] [Abstract][Full Text] [Related]
30. [Economic evaluation for the prevention of cervical cancer by vaccination--from perspective of health insurance society and industry].
Kawabayashi Y; Furuno M; Uchida M; Kawana T
Gan To Kagaku Ryoho; 2013 Apr; 40(4):493-8. PubMed ID: 23848018
[TBL] [Abstract][Full Text] [Related]
31. Sociodemographic factors and delay in the diagnosis of cervical cancer in Morocco.
Berraho M; Obtel M; Bendahhou K; Zidouh A; Errihani H; Benider A; Nejjari C
Pan Afr Med J; 2012; 12():14. PubMed ID: 22826738
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
[TBL] [Abstract][Full Text] [Related]
33. Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis.
Jewell EL; Kulasingam S; Myers ER; Alvarez Secord A; Havrilesky LJ
Gynecol Oncol; 2007 Dec; 107(3):532-40. PubMed ID: 17900674
[TBL] [Abstract][Full Text] [Related]
34. Cervical, Vaginal, and Vulvar Cancer Costs Incurred by the Medicaid Program in Publicly Insured Patients in Texas.
Fu S; Fokom Domgue J; Chan W; Zhao B; Ramondetta LM; Lairson DR
J Low Genit Tract Dis; 2019 Apr; 23(2):102-109. PubMed ID: 30907776
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Real Cost Versus the Indonesian Case Base Groups (INA-CBGs) Tariff Rates Among Patients of High- Incidence Cancers Under the National Health Insurance Scheme.
Satibi S; Andayani TM; Endarti D; Suwantara IPT; Agustini NPD
Asian Pac J Cancer Prev; 2019 Jan; 20(1):117-122. PubMed ID: 30678390
[TBL] [Abstract][Full Text] [Related]
36. Cost of care for lung cancer in the first year after diagnosis in Iran.
Mohagheghi MA; Mousavi-Jarrahi Y; Mosavi-Jarrahi A
Asian Pac J Cancer Prev; 2011; 12(4):1013-5. PubMed ID: 21790243
[TBL] [Abstract][Full Text] [Related]
37. Cost of Pediatric Visceral Leishmaniasis Care in Morocco.
Tachfouti N; Najdi A; Alonso S; Sicuri E; Laamrani El Idrissi A; Nejjari C; Picado A
PLoS One; 2016; 11(6):e0155482. PubMed ID: 27257808
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
Brar H; Hogen L; Covens A
Cancer; 2017 May; 123(10):1751-1759. PubMed ID: 28117888
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology and outcome of cervical cancer in national institute of Morocco.
Elmajjaoui S; Ismaili N; El Kacemi H; Kebdani T; Sifat H; Benjaafar N
BMC Womens Health; 2016 Sep; 16(1):62. PubMed ID: 27618814
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
